Remission and Joint Damage Progression in Early Rheumatoid Arthritis

NCT00122382 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1052

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Abatacept
DRUG: placebo
DRUG: methotrexate

Sponsor

Bristol-Myers Squibb